Followers | 50 |
Posts | 12493 |
Boards Moderated | 0 |
Alias Born | 06/15/2014 |

Thursday, March 27, 2025 4:04:53 PM
Volume: | 91 |
Day Range: | |
Bid: | 2.39 |
Ask: | 2.99 |
Last Trade Time: | 8:35:21 AM EDT |
Total Trades: | 7 |
Recent RZLT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 07:52:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2025 08:52:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2025 11:37:25 PM
- Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors • GlobeNewswire Inc. • 03/26/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 12:59:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 02:18:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 02:16:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 01:58:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 01:43:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2025 09:28:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2025 09:13:05 PM
- Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/12/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2025 10:11:05 PM
- Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism • GlobeNewswire Inc. • 02/04/2025 01:00:00 PM
- Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference • GlobeNewswire Inc. • 01/31/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2025 09:30:38 PM
- Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism • GlobeNewswire Inc. • 01/07/2025 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/30/2024 09:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 09:43:49 PM
- Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/05/2024 01:00:00 PM
- FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism • GlobeNewswire Inc. • 12/03/2024 01:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:59:50 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 02:35:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:47:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:38:45 PM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM
Opus Holdings, Inc. (OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints Visionary CEO to Lead Bold Transformation • CATV • Apr 10, 2025 9:34 AM
AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge • NGTF • Apr 10, 2025 9:00 AM
UAV Corp Powers Forward: T-Wing Nears Completion, Global Momentum Accelerates with Saudi Arabia in Sight • UMAV • Apr 10, 2025 8:30 AM
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV • FITY • Apr 9, 2025 9:00 AM
Nightfood Holdings (OTCQB: NGTF) Signs $41M LOI to Acquire Victorville Hotel as Model Property for Robotics-Enabled Hospitality • NGTF • Apr 8, 2025 11:21 AM